Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
Amgen Exercises Option for Exclusive License to Cytokinetics Cardiac Contractility Program That Includes CK-1827452
Amgen, 05/27/09
Cytokinetics Incorporated and Amgen Inc. announced that Amgen has exercised its option to obtain an exclusive license, worldwide, to Cytokinetics' cardiac contractility program. The license includes CK-1827452, a novel cardiac myosin activator being developed for the treatment of heart failure.
Today in Licensure/Accreditation...keeping you current
Receive free subspecialty "5-minute updates" via email
Myriad Genetics Acquires Exclusive Rights to Pancreatic Cancer Gene Patents From Johns Hopkins
Myriad, 10/16/09
How to Handle a Complaint from a Professional Licensure Board
The Journal for Nurse Practitioners , 10/19/09
Re-engineering hospital accreditation
Clinical Governance: An International Journal, 10/28/09
Article Search
Sponsor


See Latest Articles


